BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 1279441)

  • 1. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.
    Caux C; Dezutter-Dambuyant C; Schmitt D; Banchereau J
    Nature; 1992 Nov; 360(6401):258-61. PubMed ID: 1279441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous immune system].
    Schmitt D
    C R Seances Soc Biol Fil; 1994; 188(3):207-21. PubMed ID: 7834504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha.
    Szabolcs P; Moore MA; Young JW
    J Immunol; 1995 Jun; 154(11):5851-61. PubMed ID: 7538534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD; Stackpoole A; Meager A; Tikerpae J
    J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
    Canque B; Camus S; Yagello M; Gluckman JC
    Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Langerhans cell: from in vitro production to use in cellular immunotherapy].
    Schmitt D
    J Soc Biol; 2001; 195(1):69-74. PubMed ID: 11530504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
    Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
    Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.
    Siena S; Di Nicola M; Bregni M; Mortarini R; Anichini A; Lombardi L; Ravagnani F; Parmiani G; Gianni AM
    Exp Hematol; 1995 Dec; 23(14):1463-71. PubMed ID: 8542932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.
    Sato K; Nagayama H; Takahashi TA
    Cryobiology; 1998 Dec; 37(4):362-71. PubMed ID: 9917353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients.
    Janik JE; Miller LL; Kopp WC; Taub DD; Dawson H; Stevens D; Kostboth P; Curti BD; Conlon KC; Dunn BK; Donegan SE; Ullrich R; Alvord WG; Gause BL; Longo DL
    Clin Immunol; 1999 Dec; 93(3):209-21. PubMed ID: 10600331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and phenotypic analysis of thymic CD34+CD1a- progenitor-derived dendritic cells: predominance of CD1a+ differentiation pathway.
    Dalloul AH; Patry C; Salamero J; Canque B; Grassi F; Schmitt C
    J Immunol; 1999 May; 162(10):5821-8. PubMed ID: 10229816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.
    Strobl H; Riedl E; Scheinecker C; Bello-Fernandez C; Pickl WF; Rappersberger K; Majdic O; Knapp W
    J Immunol; 1996 Aug; 157(4):1499-507. PubMed ID: 8759731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
    Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
    Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatocyte growth factor in the development of dendritic cells from CD34+ bone marrow cells.
    Ovali E; Ratip S; Kibaroglu A; Tekelioglu Y; Cetiner M; Karti S; Aydin F; Bayik M; Akoglu T
    Haematologica; 2000 May; 85(5):464-9. PubMed ID: 10800160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow.
    Yamaguchi Y; Tsumura H; Miwa M; Inaba K
    Stem Cells; 1997; 15(2):144-53. PubMed ID: 9090791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of large numbers of Langerhans' cells with intraepithelial migration ability in vitro.
    Hubert P; Bousarghin L; Greimers R; Franzen-Detrooz E; Boniver J; Delvenne P
    Exp Dermatol; 2005 Jun; 14(6):469-77. PubMed ID: 15885083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro differenciation and functions of dendritic cells obtained from CD34+ hematopoietic progenitors].
    Dubois B; Caux C
    Pathol Biol (Paris); 1995 Dec; 43(10):829-40. PubMed ID: 8786887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.